Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   HLA-DP on Epithelial Cells enables Tissue Damage by NKp44+ NK Cells in Ulcerative Colitis
  2. Baumdick, Martin E; Niehrs, Annika; Degenhardt, Frauke; Schwerk, Maria; Hinrichs, Ole; Jordan-Paiz, Ana; Padoan, Benedetta; Wegner, Lucy H M; Schloer, Sebastian; Zecher, Britta F; Malsy, Jakob; Joshi, Vinita R; Illig, Christin; Schröder-Schwarz, Jennifer; Möller, Kimberly J; Martin,Pat; Yuki,Yuko; Ozawa, Mikki; Sauter, Jürgen; Schmidt, Alexander H; Perez, Daniel; Giannou, Anastasios D; Carrington, Mary; Davis, Randall S; Schumacher, Udo; Sauter, Guido; Huber, Samuel; Puelles, Victor G; Melling, Nathaniel; Franke, Andre; Altfeld, Marcus; Bunders, Madeleine J
  3. Gastroenterology. 2023, Oct; 165(4): 946-962.e13..
  1. 2.   The beneficial effects of commensal E. coli for colon epithelial cell recovery are related with Formyl peptide receptor 2 (Fpr2) in epithelial cells
  2. Chen,Keqiang; McCulloch, John; Das Neves, Rodrigo; Roderigues, Gisele; Hsieh,Wang-Ting; Gong,Wang; Yoshimura,Teizo; Huang, Jiaqiang; O'hUigin, Colm; Difilippantonio,Simone; McCollum, Matthew; Jones, Georgette; Durum,Scott; Trinchieri, Giorgio; Wang, Ji Ming
  3. Gut Pathogens. 2023, Jun 15; 15(1): 28.
  1. 3.   Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model
  2. Brice, Daniel P; Murray, Graeme I; Wilson, Heather M; Porter, Ross J; Berry, Susan; Durum,Scott; McLean, Mairi H
  3. Biology. 2022, Mar 11; 11(3):
  1. 4.   FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis
  2. Liang, Weiwei; Peng, Xinjian; Li, Qingqing; Wang, Pingzhang; Lv, Ping; Song, Quansheng; She, Shaoping; Huang, Shiyang; Chen,Keqiang; Gong, Wanghua; Yuan,Wuxing; Thovarai, Vishal; Yoshimura, Teizo; O'huigin, Colm; Trinchieri,Giorgio; Huang, Jiaqiang; Lin, Shuye; Yao, Xiaohong; Bian, Xiuwu; Kong, Wei; Xi, Jianzhong; Wang,Jiming; Wang, Ying
  3. Nature communications. 2020, NOV 20; 11(1): 5912.
  1. 5.   Single-organ and Multisystem hypereosinophilic syndrome patients with gastrointestinal manifestations share common characteristics
  2. Kuang, Fei Li; Curtin, Bryan F; Alao, Hawwa; Piligian, Brent; Berry, Alexis; Holland-Thomas, Nicole; Powers, Astin; Quezado, Martha; Lumbard,Keith; Fay, Michael P; Klion, Amy D; Kumar, Sheila; Khoury, Paneez
  3. The journal of allergy and clinical immunology. In practice. 2020, SEP; 8: 2718-+.
  1. 6.   Panaxynol, a bioactive component of American ginseng, targets macrophages and suppresses colitis in mice
  2. Chaparala, Anusha; Poudyal, Deepak; Tashkandi, Hossam; Witalison, Erin E; Chumanevich, Alexander A; Hofseth, Jenna L; Nguyen, Ivy; Hardy, Olivia; Pittman, Douglas L; Wyatt, Michael D; Windust, Anthony; Murphy, Elizabeth A; Nagarkatti, Mitzi; Nagarkatti, Prakash; Hofseth, Lorne J
  3. Oncotarget. 2020, Jun 02; 11(22): 2026-2036.
  1. 7.   Formyl Peptide Receptor 2 Orchestrates Mucosal Protection Against Citrobacter rodentium Infection
  2. Sharba, S; Venkatakrishnan, V; Padra, M; Whinter, M; Gabl, M; Sundqvist, M; Wang,Jiming; Forsman, H; Linden, S K
  3. Virulence. 2019, Jun 24; 10(1): 610-624.
  1. 8.   Intestinal non-canonical NF kappa B signaling shapes the local and systemic immune response
  2. Ramakrishnan, Sadeesh K.; Zhang, Huabing; Ma, Xiaoya; Jung, Inkyung; Schwartz, Andrew J.; Triner, Daniel; Devenport, Samantha N.; Das, Nupur K.; Xue, Xiang; Zeng, Melody Y.; Hu,Yinling; Mortensen, Richard M.; Greenson, Joel K.; Cascalho, Marilia; Wobus, Christiane E.; Colacino, Justin A.; Nunez, Gabriel; Rui, Liangyou; Shah, Yatrik M.
  3. Nature communications. 2019, Feb 8; 10(1):
  1. 9.   Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
  2. Kayraklioglu, Neslihan; Scheiermann, Julia; Alvord, W. Gregory; Klinman, Dennis
  3. MOLECULAR THERAPY-NUCLEIC ACIDS. 2017, Sep 15; 8: 243-249.
  1. 10.   Gut microbiota and probiotics in colon tumorigenesis
  2. Zhu, Y. M.; Luo, T. M.; Jobin, C.; Young, H. A.
  3. Cancer Letters. 2011, Oct; 309(2): 119-127.
  1. 11.   A Distal Enhancer in Il12b Is the Target of Transcriptional Repression by the STAT3 Pathway and Requires the Basic Leucine Zipper (B-ZIP) Protein NFIL3
  2. Smith, A. M.; Qualls, J. E.; O'Brien, K.; Balouzian, L.; Johnson, P. F.; Schultz-Cherry, S.; Smale, S. T.; Murray, P. J.
  3. Journal of Biological Chemistry. 2011, Jul; 286(26): 23582-23590.
  1. 12.   Localized Delivery of Interferon-beta by Lactobacillus Exacerbates Experimental Colitis
  2. McFarl, A. P.; Savan, R.; Wagage, S.; Addison, A.; Ramakrishnan, K.; Karwan, M.; Tri, D.; Young, H. A.
  3. Plos One. 2011, Feb; 6(2): 13.
  1. 13.   Innate immune mechanisms of colitis and colitis-associated colorectal cancer
  2. Saleh, M.; Trinchieri, G.
  3. Nature Reviews Immunology. 2011, Jan; 11(1): 9-20.
  1. 14.   MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
  2. Salcedo, R.; Worschech, A.; Cardone, M.; Jones, Y.; Gyulai, Z.; Dai, R. M.; Wang, E. N.; Ma, W.; Haines, D.; O'HUigin, C.; Marincola, F. M.; Trinchieri, G.
  3. Journal of Experimental Medicine. 2010, Aug 2; 207(8): 1625-1636.
  1. 15.   Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease
  2. Shen, W.; Durum, S. K.
  3. Neurochemical Research. 2010, Jun; 35(6): 940-946.
  1. 16.   NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
  2. Watanabe, T.; Asano, N.; Fichtner-Feigl, S.; Gorelick, P. L.; Tsuji, Y.; Matsumoto, Y.; Chiba, T.; Fuss, I. J.; Kitani, A.; Strober, W.
  3. Journal of Clinical Investigation. 2010, May; 120(5): 1645-1662.
  1. 17.   STAT2 Contributes to Promotion of Colorectal and Skin Carcinogenesis
  2. Gamero, A. M.; Young, M. R.; Mentor-Marcel, R.; Bobe, G.; Scarzello, A. J.; Wise, J.; Colburn, N. H.
  3. Cancer Prevention Research. 2010, Apr; 3(4): 495-504.
  1. 18.   Probiotics: From Bench to Market
  2. Klein, M.; Sanders, M. E.; Duong, T.; Young, H. A.
  3. Probiotics: From Bench to Market. 2010; 1212 : E1-E14.
  1. 19.   Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells
  2. Mannon, P. J.; Leon, F.; Fuss, I. J.; Walter, B. A.; Begnami, M.; Quezado, M.; Yang, Z.; Yi, C.; Groden, C.; Friend, J.; Hornung, R. L.; Brown, M.; Gurprasad, S.; Kelsall, B.; Strober, W.
  3. Clinical and Experimental Immunology. 2009 155(3): 447-456.
  1. 20.   Treatment of classic Kaposi sarcoma with a nicotine dermal patch: a phase II clinical trial
  2. Goedert, J. J.; Scoppio, B. M.; Pfeiffer, R.; Neve, L.; Federici, A. B.; Long, L. R.; Dolan, B. M.; Brambati, M.; Bellinvia, M.; Lauria, C.; Preiss, L.; Boneschi, V.; Whitby, D.; Brambilla, L.
  3. Journal of the European Academy of Dermatology and Venereology. 2008 22(9): 1101-1109.
  1. 21.   Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1
  2. Gruber, S. G.; Luciani, M. G.; Grundtner, P.; Zdanov, A.; Gasche, C.
  3. European Journal of Immunology. 2008 38(12): 3365-3375.
  1. 22.   Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
  2. Potocnik, U.; Glavac, D.; Dean, M.
  3. Cancer Genetics and Cytogenetics. 2008 183(1): 28-34.
  1. 23.   Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease
  2. Adachi, M.; Kurotani, R.; Morimura, K.; Shah, Y.; Sanford, M.; Madison, B. B.; Gumucio, D. L.; Marin, H. E.; Peters, J. M.; Young, H. A.; Gonzalez, F. J.
  3. Gut. 2006, Aug; 55(8): 1104-1113.
  1. 24.   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
  2. Fuss, I. J.; Becker, C.; Yang, Z. Q.; Groden, C.; Hornung, R. L.; Heller, F.; Neurath, M. F.; Strober, W.; Mannon, P. J.
  3. Inflammatory Bowel Diseases. 2006, JAN; 12(1): 9-15.
  1. 25.   Anti-interleukin-12 antibody for active Crohn's disease
  2. Mannon, P. J.; Fuss, I. J.; Mayer, L.; Elson, C. O.; Sandborn, W. J.; Present, D.; Dolin, B.; Goodman, N.; Groden, C.; Hornung, R. L.; Quezado, M.; Neurath, M. F.; Salfeld, J.; Veldman, G. M.; Schwertschlag, U.; Strober, W.
  3. New England Journal of Medicine. 2004, NOV 11; 351(20): 2069-2079.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel